Sterling Investment Advisors (Pennsylvania)’s Oramed Pharmaceuticals ORMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-3,150
| Closed | -$14K | – | 373 |
|
|
2022
Q2 | $14K | Hold |
3,150
| – | – | ﹤0.01% | 364 |
|
|
2022
Q1 | $27K | Hold |
3,150
| – | – | 0.01% | 330 |
|
|
2021
Q4 | $45K | Hold |
3,150
| – | – | 0.01% | 268 |
|
|
2021
Q3 | $69K | Hold |
3,150
| – | – | 0.02% | 222 |
|
|
2021
Q2 | $42K | Hold |
3,150
| – | – | 0.01% | 276 |
|
|
2021
Q1 | $32K | Hold |
3,150
| – | – | 0.01% | 274 |
|
|
2020
Q4 | $13K | Hold |
3,150
| – | – | ﹤0.01% | 343 |
|
|
2020
Q3 | $8K | Hold |
3,150
| – | – | ﹤0.01% | 360 |
|
|
2020
Q2 | $11K | Hold |
3,150
| – | – | ﹤0.01% | 340 |
|
|
2020
Q1 | $9K | Hold |
3,150
| – | – | ﹤0.01% | 322 |
|
|
2019
Q4 | $16K | Hold |
3,150
| – | – | 0.01% | 314 |
|
|
2019
Q3 | $10K | Hold |
3,150
| – | – | 0.01% | 340 |
|
|
2019
Q2 | $11K | Hold |
3,150
| – | – | 0.01% | 344 |
|
|
2019
Q1 | $11K | Hold |
3,150
| – | – | 0.01% | 337 |
|
|
2018
Q4 | $9K | Hold |
3,150
| – | – | 0.01% | 337 |
|
|
2018
Q3 | $15K | Hold |
3,150
| – | – | 0.01% | 329 |
|
|
2018
Q2 | $23K | Hold |
3,150
| – | – | 0.01% | 283 |
|
|
2018
Q1 | $21K | Hold |
3,150
| – | – | 0.01% | 273 |
|
|
2017
Q4 | $28K | Hold |
3,150
| – | – | 0.02% | 238 |
|
|
2017
Q3 | $31K | Hold |
3,150
| – | – | 0.02% | 225 |
|
|
2017
Q2 | $24K | Hold |
3,150
| – | – | 0.02% | 240 |
|
|
2017
Q1 | $19K | Hold |
3,150
| – | – | 0.01% | 252 |
|
|
2016
Q4 | $19K | Buy |
+3,150
| New | +$19K | 0.02% | 223 |
|